Piper Jaffray Starts AstraZeneca (AZN) at Overweight
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Piper Jaffray initiated coverage on AstraZeneca (NYSE: AZN) with an Overweight rating.
Shares of AstraZeneca closed at $34.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allergan to Present New Data from its Anti-Infectives Portfolio at IDWeek 2016 in New Orleans
- UPDATE: Seaport Global Securities Starts Canadian Pacific Railway Limited (CP) at Buy
- UPDATE: Seaport Global Securities Starts Union Pacific (UNP) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesPiper Jaffray
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!